Congestive heart failure: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
mNo edit summary |
||
| Line 20: | Line 20: | ||
==[[Congestive heart failure overview|Overview]]== | ==[[Congestive heart failure overview|Overview]]== | ||
==[[Congestive heart failure classification|Classification]]== | |||
==[[Congestive heart failure pathophysiology|Pathophysiology]]== | ==[[Congestive heart failure pathophysiology|Pathophysiology]]== | ||
==[[Congestive heart failure | ====[[Congestive heart failure pathology|Pathology]]==== | ||
==[[Congestive heart failure epidemiology and demographics|Epidemiology and Demographics]]== | ==[[Congestive heart failure epidemiology and demographics|Epidemiology and Demographics]]== | ||
==[[Congestive heart failure natural history, complications & prognosis|Natural history, complications & prognosis]]== | |||
==[[Congestive heart failure etiology|Causes]]== | |||
==[[Congestive heart failure risk factors| Risk Factors]]== | ==[[Congestive heart failure risk factors| Risk Factors]]== | ||
==[[Congestive heart failure | |||
===[[Congestive heart failure differential diagnosis|Differential Diagnosis]]=== | |||
==Diagnosis== | ==Diagnosis== | ||
===[[Congestive heart failure imaging modalities|Imaging Modalities]]=== | ====[[Congestive heart failure clinical assessment|Clinical Assessment]]==== | ||
====[[Congestive heart failure imaging modalities|Imaging Modalities]]==== | |||
==Treatment== | ==Treatment== | ||
===[[Congestive heart failure overview of treatment|Treatment Overview]]=== | |||
===[[Congestive heart failure treatment of patients at high risk for developing heart failure (Stage A)|Treatment of Patients at High Risk for Developing Heart Failure (Stage A)]]=== | ====[[Congestive heart failure overview of treatment|Treatment Overview]]==== | ||
===[[Congestive heart failure treatment of patients with cardiac structural abnormalities or remodeling who have not developed heart failure symptoms (Stage B)|Treatment of Patients with Cardiac Structural Abnormalities or Remodeling who have not Developed Heart Failure Symptoms (Stage B)]]=== | |||
===[[Congestive heart failure treatment of patients with current or prior symptoms of heart failure (Stage C)|Treatment of Patients with Current or Prior Symptoms of Heart Failure (Stage C)]]=== | ====[[Congestive heart failure treatment of patients at high risk for developing heart failure (Stage A)|Treatment of Patients at High Risk for Developing Heart Failure (Stage A)]]==== | ||
===[[Congestive heart failure treatment of patients with refractory end-stage heart failure (Stage D)|Treatment of Patients With Refractory End-Stage Heart Failure (Stage D)]]=== | |||
===[[Congestive heart failure treatment of special populations|Treatment of Special Populations]]=== | ====[[Congestive heart failure treatment of patients with cardiac structural abnormalities or remodeling who have not developed heart failure symptoms (Stage B)|Treatment of Patients with Cardiac Structural Abnormalities or Remodeling who have not Developed Heart Failure Symptoms (Stage B)]]==== | ||
===[[Congestive heart failure treatment patients who have concomitant disorders|Treatment of Patients with Heart Failure who have Concomitant Disorders]]=== | |||
====[[Congestive heart failure treatment of patients with current or prior symptoms of heart failure (Stage C)|Treatment of Patients with Current or Prior Symptoms of Heart Failure (Stage C)]]==== | |||
====[[Congestive heart failure treatment of patients with refractory end-stage heart failure (Stage D)|Treatment of Patients With Refractory End-Stage Heart Failure (Stage D)]]==== | |||
====[[Congestive heart failure treatment of special populations|Treatment of Special Populations]]==== | |||
====[[Congestive heart failure treatment patients who have concomitant disorders|Treatment of Patients with Heart Failure who have Concomitant Disorders]]==== | |||
==[[Congestive heart failure end-of-life considerations|End-Of-Life Considerations]]== | ==[[Congestive heart failure end-of-life considerations|End-Of-Life Considerations]]== | ||
| Line 46: | Line 62: | ||
==[[Congestive heart failure implementation of practice guidelines|Implementation of Practice Guidelines]]== | ==[[Congestive heart failure implementation of practice guidelines|Implementation of Practice Guidelines]]== | ||
== | ==Guidelines Resources== | ||
* The ACC/AHA 2005 Guideline Update for the Diagnosis and Management of Chronic Heart Failure in the Adult <ref name=" | *[http://circ.ahajournals.org/content/112/12/e154.full.pdf The ACC/AHA 2005 Guideline Update for the Diagnosis and Management of Chronic Heart Failure in the Adult] <ref name="pmid16160202">Hunt SA, Abraham WT, Chin MH, Feldman AM, Francis GS, Ganiats TG et al. (2005) [http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&retmode=ref&cmd=prlinks&id=16160202 ACC/AHA 2005 Guideline Update for the Diagnosis and Management of Chronic Heart Failure in the Adult: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Update the 2001 Guidelines for the Evaluation and Management of Heart Failure): developed in collaboration with the American College of Chest Physicians and the International Society for Heart and Lung Transplantation: endorsed by the Heart Rhythm Society.] ''Circulation'' 112 (12):e154-235. [http://dx.doi.org/10.1161/CIRCULATIONAHA.105.167586 DOI:10.1161/CIRCULATIONAHA.105.167586] PMID: [http://pubmed.gov/16160202 16160202]</ref> | ||
*[http://content.onlinejacc.org/cgi/reprint/53/15/1343.pdf 2009 focused update: ACCF/AHA Guidelines for the Diagnosis and Management of Heart Failure in Adults: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines: developed in collaboration with the International Society for Heart and Lung Transplantation] <ref name="pmid19324967">Jessup M, Abraham WT, Casey DE, Feldman AM, Francis GS, Ganiats TG et al. (2009) [http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&retmode=ref&cmd=prlinks&id=19324967 2009 focused update: ACCF/AHA Guidelines for the Diagnosis and Management of Heart Failure in Adults: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines: developed in collaboration with the International Society for Heart and Lung Transplantation.] ''Circulation'' 119 (14):1977-2016. [http://dx.doi.org/10.1161/CIRCULATIONAHA.109.192064 DOI:10.1161/CIRCULATIONAHA.109.192064] PMID: [http://pubmed.gov/19324967 19324967]</ref> | |||
==References== | ==References== | ||
{{Reflist|2}} | {{Reflist|2}} | ||
[[Category: | [[Category:Disease]] | ||
[[Category:Cardiology]] | [[Category:Cardiology]] | ||
[[Category:Emergency medicine]] | [[Category:Emergency medicine]] | ||
Revision as of 02:03, 2 November 2011
For patient information click here
| Heart failure | |
| ICD-10 | I50.0 |
|---|---|
| ICD-9 | 428.0 |
| DiseasesDB | 16209 |
| MedlinePlus | 000158 |
| MeSH | D006333 |
| Congestive Heart Failure Microchapters |
|
Pathophysiology |
|---|
|
Differentiating Congestive heart failure from other Diseases |
|
Diagnosis |
|
Treatment |
|
Medical Therapy: |
|
Surgical Therapy: |
|
ACC/AHA Guideline Recommendations
|
|
Specific Groups: |
|
Congestive heart failure On the Web |
|
Risk calculators and risk factors for Congestive heart failure |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-In-Chief: Cafer Zorkun, M.D., Ph.D. [2]; Atif Mohammad, MD
Synonyms and Related Key Words: CHF, pump failure, left heart failure, right heart failure, chronic heart failure, acute heart failure, flash pulmonary edema, congestion, systolic dysfunction, LV dysfunction, LV failure, impaired filling, reduced cardiac output, pulmonary edema
Overview
Classification
Pathophysiology
Pathology
Epidemiology and Demographics
Natural history, complications & prognosis
Causes
Risk Factors
Differential Diagnosis
Diagnosis
Clinical Assessment
Imaging Modalities
Treatment
Treatment Overview
Treatment of Patients at High Risk for Developing Heart Failure (Stage A)
Treatment of Patients with Cardiac Structural Abnormalities or Remodeling who have not Developed Heart Failure Symptoms (Stage B)
Treatment of Patients with Current or Prior Symptoms of Heart Failure (Stage C)
Treatment of Patients With Refractory End-Stage Heart Failure (Stage D)
Treatment of Special Populations
Treatment of Patients with Heart Failure who have Concomitant Disorders
End-Of-Life Considerations
Implementation of Practice Guidelines
Guidelines Resources
- The ACC/AHA 2005 Guideline Update for the Diagnosis and Management of Chronic Heart Failure in the Adult [1]
- 2009 focused update: ACCF/AHA Guidelines for the Diagnosis and Management of Heart Failure in Adults: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines: developed in collaboration with the International Society for Heart and Lung Transplantation [2]
References
- ↑ Hunt SA, Abraham WT, Chin MH, Feldman AM, Francis GS, Ganiats TG et al. (2005) ACC/AHA 2005 Guideline Update for the Diagnosis and Management of Chronic Heart Failure in the Adult: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Update the 2001 Guidelines for the Evaluation and Management of Heart Failure): developed in collaboration with the American College of Chest Physicians and the International Society for Heart and Lung Transplantation: endorsed by the Heart Rhythm Society. Circulation 112 (12):e154-235. DOI:10.1161/CIRCULATIONAHA.105.167586 PMID: 16160202
- ↑ Jessup M, Abraham WT, Casey DE, Feldman AM, Francis GS, Ganiats TG et al. (2009) 2009 focused update: ACCF/AHA Guidelines for the Diagnosis and Management of Heart Failure in Adults: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines: developed in collaboration with the International Society for Heart and Lung Transplantation. Circulation 119 (14):1977-2016. DOI:10.1161/CIRCULATIONAHA.109.192064 PMID: 19324967